Hong Kong Researchers Find Common Ulcer Drug Could Be Effective in Halting Coronavirus Replication in Patients

• Hong Kong Researchers Find Common Ulcer Drug Could Be Effective in Halting Coronavirus Replication in Patients
  by https://www.todayonline.com/
  HONG KONG — A drug commonly used to treat stomach ulcers has shown promise in preventing the Sars-CoV-2 coronavirus from replicating in an animal model, a study by Hong Kong’s top university has found.
  –
  The findings of the research, led by University of Hong Kong (HKU) scientists and published in Nature Microbiology on Wednesday (Oct 14), could provide a new and readily available treatment option for Sars-CoV-2, the virus that causes the disease Covid-19.
  –
  The researchers said the drug, ranitidine bismuth citrate (RBC), could achieve similar outcomes to the coronavirus drug remdesivir, but at a lower cost. RBC contains a metal called bismuth, which researchers said could reduce viral loads in coronavirus-infected human and animal cells to less than a thousandth of their previous levels.
  –
  read more.

end